Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Mónika Katkó"'
Autor:
Janos K. Aranyosi, Erika Galgoczi, Annamaria Erdei, Monika Katko, Mariann Fodor, Zoltan Ujhelyi, Ildiko Bacskay, Endre V. Nagy, Bernadett Ujhelyi
Publikováno v:
Molecules, Vol 27, Iss 9, p 3001 (2022)
Thyroid autoimmunity in Graves’ disease (GD) is accompanied by Graves’ orbitopathy (GO) in 40% of the cases. Orbital fibroblasts (OF) play a key role in the pathogenesis and cigarette smoking is a known deteriorating factor. Alongside conventiona
Externí odkaz:
https://doaj.org/article/9af07e254455499ea2e863ea4ff27fd4
Autor:
Eszter Berta, Sándor Halmi, István Molnár, Dávid Hutkai, Sára Csiha, Harjit Pal Bhattoa, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi, György Paragh, Endre V. Nagy, Miklós Bodor
Publikováno v:
Metabolites, Vol 14, Iss 10, p 565 (2024)
Background/Objectives: Fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism exerting protection against atherosclerosis by multiple actions on the blood vessels, liver, and adipose tissues. We aimed to investiga
Externí odkaz:
https://doaj.org/article/8ecbed7c95b64e63ab09e87007eb0ac2
Autor:
Sára Csiha, István Molnár, Sándor Halmi, Dávid Hutkai, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi, György Paragh, Endre V. Nagy, Eszter Berta, Miklós Bodor
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundAdvanced glycation end products (AGEs) are heterogenous group of irreversible chemical moieties originated from non-enzymatic glycation and oxidation of proteins, nucleic acids, and lipids. The engagement of AGEs with their chief cellular r
Externí odkaz:
https://doaj.org/article/cad884cd3a234e82a3ef85cfed3638fc
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Introduction This study aimed to investigate the sustained safety and efficacy of insulin treatment simplification with IDegLira in patients with type 2 diabetes and an HbA1c ≤ 7.5% (58 mmol/mol) during a 12‐month follow‐up. Methods Se
Externí odkaz:
https://doaj.org/article/104e6236325449ae808b50f6dbae53b7
Publikováno v:
Endocrinology, Diabetes & Metabolism. 6
This study aimed to investigate the sustained safety and efficacy of insulin treatment simplification with IDegLira in patients with type 2 diabetes and an HbA1c ≤ 7.5% (58 mmol/mol) during a 12-month follow-up.Seventy-two adults with type 2 diabet
Publikováno v:
Diabetologia Hungarica. 29:39-46
A kardiális autonóm neuropathia (CAN) a cukorbetegség gyakori mikrovaszkuláris szövődménye, amely összefüggést mutat a kardiovaszkuláris betegségekkel. A CAN diagnosztikájára a Ewing-féle kardiovaszkuláris reflextesztek használatosak
Publikováno v:
Diabetologia Hungarica. 28:33-42
Publikováno v:
Diabetes Therapy
Introduction Type 2 diabetic patients suffering from severe hyperglycemia are often assigned a regimen involving multiple daily injections (MDI) of insulin. If the glucose toxicity resolves, the regimen can potentially be simplified, but there are no
Publikováno v:
Nagy, E V, Perros, P, Papini, E, Katko, M & Hegedüs, L 2021, ' New Formulations of Levothyroxine in the Treatment of Hypothyroidism : Trick or Treat? ', Thyroid, vol. 31, no. 2, pp. 193-201 . https://doi.org/10.1089/thy.2020.0515
Background: Levothyroxine (LT4) as a medication is used by up to 5.3% of the adult population. For optimal efficacy, the traditional tablet formulation (LT4tab) requires that patients avoid concomitant ingestion with food, drinks, and certain medicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b177815f3a1eca0ed0a20769458c404a
https://portal.findresearcher.sdu.dk/da/publications/e5c35659-0f10-438e-b7fd-e15e871702fb
https://portal.findresearcher.sdu.dk/da/publications/e5c35659-0f10-438e-b7fd-e15e871702fb
Autor:
Balázs Bótyik, Péter Kempler, Tamás Várkonyi, Mónika Katkó, András Gyimesi, Agneta Veres, Zoltán Taybani
Publikováno v:
Diabetologia Hungarica. 29:57-58